So TRx up 7.6% wow, while NRx up .4% wow. A mixed picture, but certainly positive for GILD.
N.b., as I learned from 'The Antidote' (where CVS Pharmacy withheld its Incivek prescription reports for several weeks in 2011, causing a double digit drop in VRTX), such reports can be quite inaccurate, or at least lumpy.